CSPM EDP Sciences logo
Access to submission and peer review system
Search
Menu
All issues Volume 7 (2026) Vis Cancer Med, 7 (2026) 4 References
Open Access
Review
Issue
Vis Cancer Med
Volume 7, 2026
Article Number 4
Number of page(s) 8
DOI https://doi.org/10.1051/vcm/2026004
Published online 24 July 2026
  1. Daugherty EC, Zhang Y, Xiao Z, et al. FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approach. Radiat Oncol. 2024;19(1):34. https://doi.org/10.1186/s13014-024-02419-4. [Google Scholar]
  2. Mascia AE, Daugherty EC, Zhang Y, et al. Proton FLASH radiotherapy for the treatment of symptomatic bone metastases: the FAST-01 nonrandomized trial. JAMA Oncol. 2023;9(1):62–69. https://doi.org/10.1001/jamaoncol.2022.5843. [Google Scholar]
  3. Parikh PJ, Lee P, Low DA, et al. A multi-institutional phase 2 trial of ablative 5-fraction stereotactic magnetic resonance-guided on-table adaptive radiation therapy for borderline resectable and locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2023;117(4):799–808. https://doi.org/10.1016/j.ijrobp.2023.05.023. [Google Scholar]
  4. Kishan AU, Ma TM, Lamb JM, et al. Magnetic resonance imaging-guided vs computed tomography-guided stereotactic body radiotherapy for prostate cancer: the MIRAGE randomized clinical trial. JAMA Oncol. 2023;9(3):365–373. https://doi.org/10.1001/jamaoncol.2022.6558. [Google Scholar]
  5. de Mol van Otterloo SR, Christodouleas JP, Blezer ELA, et al. The MOMENTUM study: an international registry for the evidence-based introduction of MR-guided adaptive therapy. Front. Oncol. 2020;10:1328. https://doi.org/10.3389/fonc.2020.01328. [Google Scholar]
  6. Lambin P, Leijenaar RTH, Deist TM, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14(12):749–762. https://doi.org/10.1038/nrclinonc.2017.141. [Google Scholar]
  7. Vandewinckele L, Claessens M, Dinkla A, et al. Overview of artificial intelligence-based applications in radiotherapy: recommendations for implementation and quality assurance. Radiother Oncol. 2020;153:55–66. https://doi.org/10.1016/j.radonc.2020.09.008. [Google Scholar]
  8. Sgouros G, Bodei L, McDevitt MR, Nedrow JR. Radiopharmaceutical therapy in cancer: clinical advances and challenges. Nat Rev Drug Discov. 2020;19(9):589–608. https://doi.org/10.1038/s41573-020-0073-9. [Google Scholar]
  9. Sartor O, de Bono J, Chi KN, et al. Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer. N Engl J Med. 2021;385(12):1091–1103. https://doi.org/10.1056/NEJMoa2107322. [Google Scholar]
  10. Strosberg J, El-Haddad G, Wolin E, et al. Phase 3 trial of 177Lu-Dotatate for midgut neuroendocrine tumors. N Engl J Med. 2017;376(2):125–135. https://doi.org/10.1056/NEJMoa1607427. [Google Scholar]
  11. Amendola BE, Mahadevan A, Blanco Suarez JM, et al. An international consensus on the design of prospective clinical-translational trials in spatially fractionated radiation therapy for advanced gynecologic cancer. Cancers (Basel). 2022;14(17):4267. https://doi.org/10.3390/cancers14174267. [Google Scholar]
  12. Lukas L, Zhang H, Cheng K, Epstein A. Immune priming with spatially fractionated radiation therapy. Curr Oncol Rep. 2023;25(12):1483–1496. https://doi.org/10.1007/s11912-023-01473-7. [Google Scholar]
  13. Wu X, Perez NC, Zheng Y, Li X, Jiang L, Amendola BE, Xu B, Mayr NA, Lu JJ, Hatoum GF, Zhang H, Chang SX, Griffin RJ, Guha C. The technical and clinical implementation of LATTICE radiation therapy (LRT). Radiat Res. 2020;194(6):737–746. https://doi.org/10.1667/RADE-20-00066.1. [Google Scholar]
  14. Peeters A, Grutters JPC, Pijls-Johannesma M, et al. How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons. Radiother Oncol. 2010;95(1):45–53. https://doi.org/10.1016/j.radonc.2009.12.002 [Google Scholar]
  15. Liney GP, Whelan B, Oborn B, et al. MRI-linear accelerator radiotherapy systems. Clin Oncol (R Coll Radiol). 2018;30(11):686–691. https://doi.org/10.1016/j.clon.2018.08.003. [Google Scholar]
  16. Kerstiens J, Johnstone GP, Johnstone PAS. Proton facility economics: single-room centers. J Am Coll Radiol. 2018;15(12):1704–1708. https://doi.org/10.1016/j.jacr.2018.07.020. [Google Scholar]
  17. Perkins SM, Prime S, Watts M, et al. Pediatric experience and outcomes from the first single-vault compact proton therapy center. Cancers (Basel). 2023;15(16):4072. https://doi.org/10.3390/cancers15164072. [Google Scholar]
  18. Atun R, Jaffray DA, Barton MB, et al. Expanding global access to radiotherapy. Lancet Oncol. 2015;16(10):1153–1186. https://doi.org/10.1016/S1470-2045(15)00222-3. [Google Scholar]
  19. Bortfeld TR, Loeffler JS. Three ways to make proton therapy affordable. Nature. 2017;549(7673):451–453. https://doi.org/10.1038/549451a. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.